FDA Approves TRAMADOL HYDROCHLORIDE — Cranbury Pharmaceuticals, LLC

Cranbury Pharmaceuticals, LLC received FDA approval for its ANDA covering Tramadol Hydrochloride tablets, granting the company authorization to market the generic version of this prescription painkiller. This regulatory clearance enables Cranbury to expand its product portfolio and capitalize on the established market for opioid medications.